Disconnect Between Genes Associated With Ischemic Heart Disease and Targets of Ischemic Heart Disease Treatments

BACKGROUND: Development of pharmacological treatments to mitigate ischemic heart disease (IHD) has encompassed disappointing results and expensive failures, which has discouraged investment in new approaches to prevention and control. New treatments are most likely to be successful if they act on ge...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:EBioMedicine
Main Authors: Schooling, C.M., Huang, J.V., Zhao, J.V., Kwok, M.K., Au Yeung, S.L., Lin, S.L.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2018
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5835561/
https://ncbi.nlm.nih.gov/pubmed/29396305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2018.01.015
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki